Prof. Dr. med. David Brenner is a German neurologist and researcher specializing in neurogenetics and neurodegenerative diseases. He is a senior physician at the University Hospital of Ulm and leads a research group in translational neurogenetics.
His work focuses on the genetic and molecular mechanisms of motor neuron diseases, particularly amyotrophic lateral sclerosis (ALS), with the aim of developing gene-targeted therapies. He has contributed to the discovery of several ALS-associated genes, including NEK1, KIF5A, and TBK1.
He is also actively involved in clinical care and international research efforts, bridging laboratory discoveries with patient treatment.
Groups
David is involved in these different areas of the network...
